Advisory Committee on Organ Transplantation; Request for Nominations for Voting Members, 111-112 [E8-31219]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 1 / Friday, January 2, 2009 / Notices
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by January 12, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Elaine
Ferguson at least 7 days in advance of
the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: December 19, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8–31217 Filed 12–31–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Committee on Organ
Transplantation; Request for
Nominations for Voting Members
mstockstill on PROD1PC66 with NOTICES
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice.
SUMMARY: The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill vacancies
on the Advisory Committee on Organ
Transplantation (ACOT). The ACOT
was established by the Amended Final
Rule of the Organ Procurement and
Transplantation Network (OPTN) (42
CFR Part 121) and, in accordance with
Public Law 92–463, was chartered on
September 1, 2000.
DATES: The agency must receive
nominations on or before February 2,
2009.
ADDRESSES: All nominations should be
submitted to the Executive Secretary,
VerDate Aug<31>2005
16:23 Dec 31, 2008
Jkt 217001
Advisory Committee on Organ
Transplantation, Healthcare Systems
Bureau, HRSA, Parklawn Building,
Room 12–105, 5600 Fishers Lane,
Rockville, Maryland 20857. Federal
Express, Airborne, UPS, etc., mail
delivery should be addressed to
Executive Secretary, Advisory
Committee on Organ Transplantation,
Healthcare Systems Bureau, HRSA, at
the above address.
FOR FURTHER INFORMATION CONTACT:
Remy Aronoff, Executive Secretary,
Advisory Committee on Organ
Transplantation, at (301) 443–3300 or email Remy.Aronoff@hrsa.hhs.gov.
SUPPLEMENTARY INFORMATION: As
provided by 42 CFR 121.12 (64 FR
56661), the Secretary established the
Advisory Committee on Organ
Transplantation. The Committee is
governed by the Federal Advisory
Committee Act (5 U.S.C. Appendix 2),
which sets forth standards for the
formation and use of advisory
committees.
The ACOT advises the Secretary,
acting through the Administrator,
HRSA, on all aspects of organ
procurement, allocation, and
transplantation, and on other such
matters that the Secretary determines.
One of its principal functions is to
advise the Secretary on ways to
maximize Federal efforts to increase
living and deceased organ donation
nationally. Other matters that recently
have been reviewed by the ACOT
include:
• Accreditation of all establishments
required to be registered with the FDA
as manufacturers of human cells,
tissues, and cellular- and tissue-based
products;
• Concerns about U.S. citizens
traveling abroad in order to receive
organ transplants (also known as
transplant tourism);
• Collection of data on the long-term
health status of living donors;
• Organ Procurement and
Transplantation Network development
and distribution within the transplant
community of a set of practice
guidelines to be followed with respect
to public solicitation of organ donors,
both living and deceased; and
• Standards of coverage for living
donors relating to future adverse events.
The ACOT consists of up to 25
members, including the Chair. Members
and Chair shall be selected by the
Secretary from individuals
knowledgeable in such fields as organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
111
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members. To the extent
practicable, Committee members should
represent the minority, gender and
geographic diversity of transplant
candidates, transplant recipients, organ
donors and family members served by
the OPTN. In addition, the Director,
Centers for Disease Control and
Prevention; the Administrator, Centers
for Medicare and Medicaid Services; the
Commissioner, Food and Drug
Administration; the Director, National
Institutes of Health; and the Director,
Agency for Healthcare Research and
Quality (or the designees of such
officials) serve as non-voting ex-officio
members.
Specifically, HRSA is requesting
nominations for voting members of the
ACOT representing: Health care public
policy; transplantation medicine and
surgery, including pediatric and heart/
lung transplantation; critical care
medicine; nursing; epidemiology and
applied statistics; immunology; law and
bioethics; behavioral sciences;
economics and econometrics; organ
procurement organizations; transplant
candidates/recipients; transplant/donor
family members; and living donors.
Nominees will be invited to serve a 4year term beginning after July 2009.
HHS will consider nominations of all
qualified individuals with a view to
ensuring that the Advisory Committee
includes the areas of subject matter
expertise noted above. Individuals may
nominate themselves or other
individuals, and professional
associations and organizations may
nominate one or more qualified persons
for membership on the ACOT.
Nominations shall state that the
nominee is willing to serve as a member
of the ACOT and appears to have no
conflict of interest that would preclude
the ACOT membership. Potential
candidates will be asked to provide
detailed information concerning
financial interests, consultancies,
research grants, and/or contracts that
might be affected by recommendations
of the Committee to permit evaluation of
possible sources of conflicts of interest.
A nomination package should include
the following information for each
nominee: (1) A letter of nomination
stating the name, affiliation, and contact
information for the nominee, the basis
for the nomination (i.e., what specific
attributes, perspectives, and/or skills
does the individual possess that would
E:\FR\FM\02JAN1.SGM
02JAN1
112
Federal Register / Vol. 74, No. 1 / Friday, January 2, 2009 / Notices
benefit the workings of ACOT), and the
nominee’s field(s) of expertise; (2) a
biographical sketch of the nominee and
a copy of his/her curriculum vitae; and
(3) the name, return address, and
daytime telephone number at which the
nominator can be contacted.
The Department of Health and Human
Services has special interest in assuring
that women, minority groups, and the
physically disabled are adequately
represented on advisory committees;
and therefore, extends particular
encouragement to nominations for
appropriately qualified female,
minority, or disabled candidates.
Dated: December 21, 2008.
Elizabeth M. Duke,
Administrator, HRSA.
[FR Doc. E8–31219 Filed 12–31–08; 8:45 am]
BILLING CODE 4165–15–P
clinical research: Type of Information
Collection Request: New. Need and Use
of Information Collection: This study
National Institutes of Health
will assess the value of the training
programs administered by the Office of
Proposed Collection; Comment
Clinical Research Training and Medical
Request; the Impact of Clinical
Education. The primary objective of the
Research Training and Medical
survey is to determine if training
Education at the Clinical Center on
programs have had an impact on
Physician Careers in Academia and
whether the trainees are performing
Clinical Research
clinical research, hold an academic
appointment, have National Institutes of
SUMMARY: In compliance with the
Health funding sources as well as to
requirement of Section 3506(c)(2)(A) of
obtain information from the trainees as
the Paperwork Reduction Act of 1995,
to what part of the National Institutes of
for opportunity for public comment on
Health medical education program they
proposed data collection projects, the
feel could be improved upon, the
Clinical Center, the National Institutes
quality of the mentoring program, and
of Health will publish periodic
how their National Institutes of Health
summaries of proposed projects to be
training has contributed to their current
submitted to the Office of Management
clinical competence. Frequency of
and Budget for review and approval.
Proposed Collection: Title: The impact response: On occasion. Affected Public:
of clinical research training and medical Physicians, dentists, medical students,
dental students, nurses, and PhDs. The
education at the Clinical Center on
annual reporting burden is as follows:
physician careers in academia and
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Estimated
number
of responses
per respondent
Estimated
number
of respondents
Type of respondents
Average burden
hours per
response
Estimated total
annual burden
hours requested
625
100
100
1
1
1
0.5
0.5
0.5
312.5
50
50
Total ........................................................................................
mstockstill on PROD1PC66 with NOTICES
Doctoral Level ................................................................................
Students .........................................................................................
Nurses ............................................................................................
............................
............................
............................
362.5
There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to
report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
the data collection plans and
instruments, contact Linda Wisniewski,
Nurse Consultant, Office of Clinical
Research Training and Medical
Education, CC, NIH, Building 10, Room
1N252B, 9000 Rockville Pike, Bethesda,
MD 20892 or 301–496–9425 or e-mail
your request, including your address to:
wisniewskil@cc.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: December 24, 2008.
Laura Lee,
Project Clearance Liaison, Warren Grant
Magnuson Clinical Center, National Institutes
of Health.
[FR Doc. E8–31240 Filed 12–31–08; 8:45 am]
BILLING CODE 4140–01–P
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
VerDate Aug<31>2005
16:23 Dec 31, 2008
Jkt 217001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY: National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
SUMMARY: The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 207 to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
ADDRESSES: Licensing information and
copies of the U.S. patent applications
listed below may be obtained by writing
to the indicated licensing contact at the
Office of Technology Transfer, National
Institutes of Health, 6011 Executive
E:\FR\FM\02JAN1.SGM
02JAN1
]]>Agencies
[Federal Register Volume 74, Number 1 (Friday, January 2, 2009)]
[Notices]
[Pages 111-112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-31219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Organ Transplantation; Request for
Nominations for Voting Members
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations to fill vacancies on the Advisory Committee on
Organ Transplantation (ACOT). The ACOT was established by the Amended
Final Rule of the Organ Procurement and Transplantation Network (OPTN)
(42 CFR Part 121) and, in accordance with Public Law 92-463, was
chartered on September 1, 2000.
DATES: The agency must receive nominations on or before February 2,
2009.
ADDRESSES: All nominations should be submitted to the Executive
Secretary, Advisory Committee on Organ Transplantation, Healthcare
Systems Bureau, HRSA, Parklawn Building, Room 12-105, 5600 Fishers
Lane, Rockville, Maryland 20857. Federal Express, Airborne, UPS, etc.,
mail delivery should be addressed to Executive Secretary, Advisory
Committee on Organ Transplantation, Healthcare Systems Bureau, HRSA, at
the above address.
FOR FURTHER INFORMATION CONTACT: Remy Aronoff, Executive Secretary,
Advisory Committee on Organ Transplantation, at (301) 443-3300 or e-
mail Remy.Aronoff@hrsa.hhs.gov.
SUPPLEMENTARY INFORMATION: As provided by 42 CFR 121.12 (64 FR 56661),
the Secretary established the Advisory Committee on Organ
Transplantation. The Committee is governed by the Federal Advisory
Committee Act (5 U.S.C. Appendix 2), which sets forth standards for the
formation and use of advisory committees.
The ACOT advises the Secretary, acting through the Administrator,
HRSA, on all aspects of organ procurement, allocation, and
transplantation, and on other such matters that the Secretary
determines. One of its principal functions is to advise the Secretary
on ways to maximize Federal efforts to increase living and deceased
organ donation nationally. Other matters that recently have been
reviewed by the ACOT include:
Accreditation of all establishments required to be
registered with the FDA as manufacturers of human cells, tissues, and
cellular- and tissue-based products;
Concerns about U.S. citizens traveling abroad in order to
receive organ transplants (also known as transplant tourism);
Collection of data on the long-term health status of
living donors;
Organ Procurement and Transplantation Network development
and distribution within the transplant community of a set of practice
guidelines to be followed with respect to public solicitation of organ
donors, both living and deceased; and
Standards of coverage for living donors relating to future
adverse events.
The ACOT consists of up to 25 members, including the Chair. Members
and Chair shall be selected by the Secretary from individuals
knowledgeable in such fields as organ donation, health care public
policy, transplantation medicine and surgery, critical care medicine
and other medical specialties involved in the identification and
referral of donors, non-physician transplant professions, nursing,
epidemiology, immunology, law and bioethics, behavioral sciences,
economics and statistics, as well as representatives of transplant
candidates, transplant recipients, organ donors, and family members. To
the extent practicable, Committee members should represent the
minority, gender and geographic diversity of transplant candidates,
transplant recipients, organ donors and family members served by the
OPTN. In addition, the Director, Centers for Disease Control and
Prevention; the Administrator, Centers for Medicare and Medicaid
Services; the Commissioner, Food and Drug Administration; the Director,
National Institutes of Health; and the Director, Agency for Healthcare
Research and Quality (or the designees of such officials) serve as non-
voting ex-officio members.
Specifically, HRSA is requesting nominations for voting members of
the ACOT representing: Health care public policy; transplantation
medicine and surgery, including pediatric and heart/lung
transplantation; critical care medicine; nursing; epidemiology and
applied statistics; immunology; law and bioethics; behavioral sciences;
economics and econometrics; organ procurement organizations; transplant
candidates/recipients; transplant/donor family members; and living
donors. Nominees will be invited to serve a 4-year term beginning after
July 2009.
HHS will consider nominations of all qualified individuals with a
view to ensuring that the Advisory Committee includes the areas of
subject matter expertise noted above. Individuals may nominate
themselves or other individuals, and professional associations and
organizations may nominate one or more qualified persons for membership
on the ACOT. Nominations shall state that the nominee is willing to
serve as a member of the ACOT and appears to have no conflict of
interest that would preclude the ACOT membership. Potential candidates
will be asked to provide detailed information concerning financial
interests, consultancies, research grants, and/or contracts that might
be affected by recommendations of the Committee to permit evaluation of
possible sources of conflicts of interest.
A nomination package should include the following information for
each nominee: (1) A letter of nomination stating the name, affiliation,
and contact information for the nominee, the basis for the nomination
(i.e., what specific attributes, perspectives, and/or skills does the
individual possess that would
[[Page 112]]
benefit the workings of ACOT), and the nominee's field(s) of expertise;
(2) a biographical sketch of the nominee and a copy of his/her
curriculum vitae; and (3) the name, return address, and daytime
telephone number at which the nominator can be contacted.
The Department of Health and Human Services has special interest in
assuring that women, minority groups, and the physically disabled are
adequately represented on advisory committees; and therefore, extends
particular encouragement to nominations for appropriately qualified
female, minority, or disabled candidates.
Dated: December 21, 2008.
Elizabeth M. Duke,
Administrator, HRSA.
[FR Doc. E8-31219 Filed 12-31-08; 8:45 am]
BILLING CODE 4165-15-P
